Clinical Trials · NCT01664247
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 346
- Start date
- Oct 2012
- Locations
- 132 sites, 11 countries
- Primary endpoint
- Change From Baseline in Glycosylated Haemoglobin (HbA1c) (%)